Overview

A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.
Phase:
Phase 2
Details
Lead Sponsor:
FemmePharma Global Healthcare, Inc.
Treatments:
Mandelic Acids
Oxybutynin